@ShahidNShah
Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease
Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and provider organizations that include this approach to testing.
At a time when America’s hospitals and physician groups face lost revenues due to the COVID-19 pandemic, there is a pressing need for reducing costs while maintaining high-quality patient care. Awareness is growing around the prevalence and costs associated with underdiagnosed liver disease, which is associated with over $100B in annual direct costs.
Continue reading at hitconsultant.net
Make faster decisions with community advice
- 3D Bioprinting - Overview of How Bioprinting Will Break Into Healthcare
- A Perspective on Herd Immunity For COVID-19
- Cognito Therapeutics Touts Positive Phase 2 Results For Device-Delivered Alzheimer's Treatment
- New Tool Lets Users Sign Up For Leftover COVID-19 Vaccines
- Patient: Doctor, Talk to Me about Benefits and Risks!
Next Article
-
New Tool Lets Users Sign Up For Leftover COVID-19 Vaccines
It's no secret the COVID-19 vaccines are a scare resource. But the combination of temperature constraints and no shows has led to vaccine waste. A new platform called Dr. B is looking to …
Posted Mar 11, 2021 COVID-19 Coronavirus Vaccine